Published in J Biol Chem on January 25, 1991
Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest (1992) 4.40
Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan. J Cell Biol (1992) 1.37
Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. Mol Biol Cell (1994) 1.35
Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol (1993) 1.33
Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin. J Cell Biol (1992) 1.23
Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes. Mol Biol Cell (1997) 1.22
A second thrombospondin gene in the mouse is similar in organization to thrombospondin 1 but does not respond to serum. Proc Natl Acad Sci U S A (1991) 1.17
A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1. J Cell Biol (2001) 1.15
Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med (1998) 1.11
Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. J Cell Biol (1993) 1.10
Structure-function and regulation of ADAMTS-13 protease. J Thromb Haemost (2013) 1.06
Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes. Mol Biol Cell (1997) 1.05
Structural insight into the role of thrombospondin-1 binding to calreticulin in calreticulin-induced focal adhesion disassembly. Biochemistry (2010) 0.95
Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea-pig skin. Br J Pharmacol (1993) 0.89
Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents. Nanomedicine (Lond) (2015) 0.80
Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1. Biochem J (1997) 0.80
Thrombospondin modulates melanoma--platelet interactions and melanoma tumour cell growth in vivo. Br J Cancer (1995) 0.78
Thrombospondin-1 binds to polyhistidine with high affinity and specificity. Biochem J (2000) 0.78
Microarray Integrated Analysis of a Gene Network for the CD36 Myocardial Phenotype. Bioinformation (2016) 0.75
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest (1973) 10.18
A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest (1989) 3.71
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30
Isolation of the thrombospondin membrane receptor. J Clin Invest (1987) 2.87
Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A (1974) 2.83
A clinical study of the lupus anticoagulant. Blood (1976) 2.81
Contractile proteins of endothelial cells, platelets and smooth muscle. Am J Pathol (1973) 2.36
Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest (1982) 2.05
Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest (1982) 2.04
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med (1986) 2.01
Thrombospondin is the endogenous lectin of human platelets. Nature (1982) 1.98
Increased vascular permeability produced by human platelet granule cationic extract. J Clin Invest (1970) 1.98
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood (1995) 1.94
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood (1994) 1.90
Binding of plasminogen to cultured human endothelial cells. J Biol Chem (1986) 1.87
Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (1989) 1.85
Cancer and clotting--Trousseau's warning. N Engl J Med (1992) 1.78
Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody. J Exp Med (1986) 1.75
Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem (1973) 1.72
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med (1986) 1.68
Rabbit platelet bactericidal protein. J Exp Med (1971) 1.63
Protein kinase CK2 mediates TGF-beta1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int (2001) 1.61
Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells. J Clin Invest (1975) 1.56
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest (1987) 1.53
Drug purpura. Semin Hematol (1965) 1.53
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J Clin Invest (1984) 1.52
A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma. Hum Pathol (1999) 1.50
Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med (1987) 1.50
Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med (1975) 1.43
Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest (1984) 1.43
Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med (1998) 1.43
Binding of plasminogen to extracellular matrix. J Biol Chem (1986) 1.38
Isolation, purification, and partial characterization of platelet membrane glycoproteins IIb and IIIa. J Biol Chem (1981) 1.37
Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem (1991) 1.36
Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun (1992) 1.32
Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest (1989) 1.32
Macrophage plasma membranes. I. Isolation and studies on protein components. J Exp Med (1971) 1.32
Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med (1979) 1.31
Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sci U S A (1986) 1.29
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood (1981) 1.28
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J Clin Invest (1987) 1.28
Immunoinhibition of ristocetin-induced platelet aggregation. J Clin Invest (1977) 1.26
Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J Clin Invest (1985) 1.24
Human platelet activation by C3a and C3a des-arg. J Exp Med (1983) 1.22
Characterization of human platelet vascular permeability-enhancing activity. J Clin Invest (1972) 1.20
Immunologic studies of proteins associated with subcellular fractions of normal human platelets. J Lab Clin Med (1967) 1.20
Thrombospondin: a versatile multifunctional glycoprotein. Arteriosclerosis (1986) 1.19
Increased skin permeability in preterm infants. J Pediatr (1971) 1.18
Structural analysis of human platelet membrane glycoprotein I complex. Proc Natl Acad Sci U S A (1979) 1.18
Studies on human platelet protease activity. J Clin Invest (1969) 1.17
Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest (1987) 1.15
Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes. J Exp Med (1981) 1.14
Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study. J Exp Med (1981) 1.13
Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex. J Exp Med (1979) 1.13
Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. J Biol Chem (1985) 1.12
Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med (1998) 1.11
Macrophage plasma membrane. II. Studies on synthesis and turnover of protein constituents. J Exp Med (1971) 1.08
Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest (2001) 1.08
Thrombocytopenia due to digitoxin. Demonstration of antibody and mechanisms of action. Am J Med (1966) 1.08
Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood (1997) 1.07
Studies on the proteins of human platelet membranes. J Biol Chem (1972) 1.06
Ultrastructure of thrombosthenin, the contractile protein of human blood platelets. Science (1967) 1.05
Human platelet membrane protein. Biochemistry (1970) 1.05
The platelet as an inflammatory cell. Ann N Y Acad Sci (1972) 1.04
Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury. J Exp Med (1975) 1.04
Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood (1983) 1.04
Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G. J Clin Invest (1978) 1.03
Platelet membrane topography: colocalization of thrombospondin and fibrinogen with the glycoprotein IIb-IIIa complex. Blood (1985) 1.03
Acquired protein S and antithrombin III deficiency caused by nephrotic syndrome: an unusual cause of graft thrombosis. J Vasc Surg (1997) 1.02
Binding of adenosine diphosphate by isolated membranes from human platelets. J Biol Chem (1974) 1.01
Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol (1997) 1.01
Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int (1996) 1.00
Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment. J Biol Chem (1988) 1.00
Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem (1996) 0.99
Glomerulosclerosis in aging humans is not influenced by gender. Am J Kidney Dis (1999) 0.99
Thrombospondin: phenomenology to function. Prog Hemost Thromb (1989) 0.99
BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics. Microvasc Res (1996) 0.98
Structural analysis of factor VIII antigen in von Willebrand disease. Proc Natl Acad Sci U S A (1980) 0.98
Human complement in the arachidonic acid transformation pathway in platelets. J Exp Med (1981) 0.97
Reed-Sternberg cells in Hodgkin's disease contain fibronectin. Blood (1981) 0.96
Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol Renal Physiol (2000) 0.96
Serum-stimulated alpha 1 type IV collagen gene transcription is mediated by TGF-beta and inhibited by estradiol. Am J Physiol (1998) 0.94
Inhibition of fibrin monomer polymerization by lambda myeloma globulins. Blood (1972) 0.93
Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. J Biol Chem (1986) 0.92
Cytokine-enhanced expression of glycoprotein Ib alpha in human endothelium. J Biol Chem (1990) 0.92
Gold-associated thrombocytopenia. Report six cases. Arch Intern Med (1974) 0.92
Multiple molecular forms of endothelial cell factor VIII related antigen. Biochim Biophys Acta (1981) 0.91
Thrombasthenia: immunologic evidence of a platelet protein abnormality. J Lab Clin Med (1966) 0.90
Nature of the defect in congenital factor V deficiency: study in a patient with an acquired circulating anticoagulant. Blood (1972) 0.90
Thrombotic thrombocytopenic purpura--coagulation parameters in twelve patients. Blood (1973) 0.89
The effect of platelet membrane antibodies on aggregation and release. Br J Haematol (1974) 0.89
Correlation of immunologic and structural heterogeneity of Bence Jones proteins. J Immunol (1966) 0.89
Immunological studies of proteins associated with the subcellular fractions of thrombasthenic and afibrinogenaemic platelets. Br J Haematol (1968) 0.89
Hypervitaminosis A in two hemodialysis patients. Am J Kidney Dis (1995) 0.88
Subtypes of Bence-Jones proteins. J Immunol (1965) 0.88
Thrombospondin forms complexes with single-chain and two-chain forms of urokinase. J Biol Chem (1990) 0.87
The effect of donor gender on renal allograft survival. J Am Soc Nephrol (1996) 0.87